XTL reports delisting from LSE
With the cancellation of the listing on the London Stock Exchange, shareholders may deposit their ordinary shares with the company’s depositary bank, The Bank of New York, in
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases.